Business Context and Reporting Period
This Form 8-K Current Report was filed by Community Healthcare Trust Incorporated (CHCT) on January 4, 2024, covering events that occurred on January 2, 2024. The filing details updates to the Company's executive compensation programs and the grant of new equity-based awards to align management interests with stockholders.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and executive compensation arrangements.
Material Changes
The Board of Directors and Compensation Committee approved significant updates to compensation structures effective January 1, 2024, and July 1, 2024:
- Alignment of Interest Program: Adopted the Third Amended and Restated program, capping elective deferrals for restricted stock acquisition at 50% of compensation for certain participants and limiting restriction period durations.
- Executive Officer Incentive Program: Adopted the Third Amended and Restated program. Company Performance Awards (CPA) now represent approximately 70% of annual incentive compensation, while Individual Performance Awards (IPA) represent approximately 30%.
- Long-Term Incentive Plan (LTIP): Future LTIP awards will consist of approximately 65% performance-based Restricted Stock Units (RSUs) and 35% time-based RSUs.
- 2014 Incentive Plan: Amended to explicitly provide for the award of RSUs.
Guidance, Outlook, and Management Commentary
Management stated that the updates are intended to conform with industry standards and market practices to attract and retain top management talent. The new structure emphasizes long-term performance alignment through Total Shareholder Return (TSR) metrics.
Equity Grant Details: On January 2, 2024, the following RSUs were granted to executive officers:
| Executive Officer | Absolute TSR RSUs (Target) | Relative TSR RSUs (Target) | Time-Based RSUs |
|---|---|---|---|
| David H. Dupuy (CEO) | 21,946 | 16,852 | 13,046 |
| William G. Monroe IV (CFO) | 13,563 | 10,415 | 8,062 |
| Leigh Ann Stach (CAO) | 12,608 | 9,682 | 7,495 |
| Timothy L. Meyer (EVP Asset Mgmt) | 8,444 | 6,484 | 5,020 |
Performance Metrics: Performance-based RSUs vest based on a three-year period commencing July 1, 2023. Vesting ranges from 0% to 200% based on:
- Absolute TSR: Threshold at 4.0% annual growth, Target at 8.0%, Maximum above 12.0%.
- Relative TSR: Threshold at 25th percentile of peer group, Target at 55th percentile, Maximum above 80th percentile.
Investor Verification Checklist
- Verify the specific vesting schedules and performance thresholds in the attached exhibits (10.1 through 10.5).
- Confirm the impact of the new 50% deferral cap on executive cash flow and equity accumulation.
- Review the definition of the "Peer Group" used for Relative TSR calculations to assess the difficulty of achieving maximum vesting.
- Monitor future filings for the actual TSR performance results at the end of the three-year performance period (June 30, 2026).